EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

T-Cell-Derived Nanovesicles Functionalized with Anti-PDL1 Antibodies for Oxaliplatin Delivery and Enhanced Antitumor Efficacy in Colorectal Cancer

Ruijie Zhou, Siya Liu, Miao Liu, Xinjuan Ma, Xiaojuan Yang, Bin Ma, Chunxia Su, Xiangguo Duan

International Journal of Nanomedicine · 2026-11 · Volume 21 · 1-23

DOI: 10.2147/ijn.s636388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026-11. Verfasst von Ruijie Zhou und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Zhou, R., Liu, S., Liu, M., Ma, X., Yang, X., Ma, B., Su, C., & Duan, X. (2026). T-Cell-Derived Nanovesicles Functionalized with Anti-PDL1 Antibodies for Oxaliplatin Delivery and Enhanced Antitumor Efficacy in Colorectal Cancer. International Journal of Nanomedicine, Volume 21, 1-23. https://doi.org/10.2147/ijn.s636388

Vancouver

Zhou R, Liu S, Liu M, Ma X, Yang X, Ma B, et al. T-Cell-Derived Nanovesicles Functionalized with Anti-PDL1 Antibodies for Oxaliplatin Delivery and Enhanced Antitumor Efficacy in Colorectal Cancer. International Journal of Nanomedicine. 2026;Volume 21:1-23. doi:10.2147/ijn.s636388

BibTeX
@article{Zhou2026,
  author = {Zhou, Ruijie and Liu, Siya and Liu, Miao and Ma, Xinjuan and Yang, Xiaojuan and Ma, Bin and Su, Chunxia and Duan, Xiangguo},
  title = {T-Cell-Derived Nanovesicles Functionalized with Anti-PDL1 Antibodies for Oxaliplatin Delivery and Enhanced Antitumor Efficacy in Colorectal Cancer},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  volume = {Volume 21},
  pages = {1--23},
  doi = {10.2147/ijn.s636388}
}
Kostenlos starten →